1-10 of 10
Albert Deisseroth
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Differentiation Syndrome with Ivosidenib and Enasidenib Treatment in Patients with Relapsed or Refractory IDH-Mutated AML: A U.S. Food and Drug Administration Systematic Analysis

Kelly J. Norsworthy, Flora Mulkey, Emma C. Scott, Ashley F. Ward, Donna Przepiorka, Rosane Charlab, Sarah E. Dorff, Albert Deisseroth, Dickran Kazandjian, Rajeshwari Sridhara, Julia A. Beaver, Ann T. Farrell, R. Angelo de Claro, Richard Pazdur
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (16): 4280–4288.
DOI: https://doi.org/10.1158/1078-0432.CCR-20-0834
Published: 14 August 2020
View article
PDF
Includes: Supplementary data
Journal Articles

FDA Approval Summary: Calaspargase Pegol-mknl For Treatment of Acute Lymphoblastic Leukemia in Children and Young Adults

Ruo-Jing Li, Runyan Jin, Chao Liu, Xianhua Cao, Michael L. Manning, Xu Michael Di, Donna Przepiorka, Frances Namuswe, Albert Deisseroth, Kirsten B. Goldberg, Gideon M. Blumenthal, Richard Pazdur
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (2): 328–331.
DOI: https://doi.org/10.1158/1078-0432.CCR-19-1255
Published: 15 January 2020
View article
PDF
Includes: Supplementary data
Journal Articles

FDA Approval Summary: Ivosidenib for Relapsed or Refractory Acute Myeloid Leukemia with an Isocitrate Dehydrogenase-1 Mutation

Kelly J. Norsworthy, Lola Luo, Vicky Hsu, Ramadevi Gudi, Sarah E. Dorff, Donna Przepiorka, Albert Deisseroth, Yuan-Li Shen, Christopher M. Sheth, Rosane Charlab, Gene M. Williams, Kirsten B. Goldberg, Ann T. Farrell, Richard Pazdur
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (11): 3205–3209.
DOI: https://doi.org/10.1158/1078-0432.CCR-18-3749
Published: 03 June 2019
View article
PDF
Includes: Supplementary data
Journal Articles

FDA Approval: Blinatumomab for Patients with B-cell Precursor Acute Lymphoblastic Leukemia in Morphologic Remission with Minimal Residual Disease

Emily Y. Jen, Qing Xu, Aaron Schetter, Donna Przepiorka, Yuan Li Shen, Donna Roscoe, Rajeshwari Sridhara, Albert Deisseroth, Reena Philip, Ann T. Farrell, Richard Pazdur
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (2): 473–477.
DOI: https://doi.org/10.1158/1078-0432.CCR-18-2337
Published: 15 January 2019
View article
PDF
Includes: Supplementary data
Journal Articles

FDA Drug Approval: Elotuzumab in Combination with Lenalidomide and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma

Nicole J. Gormley, Chia-Wen Ko, Albert Deisseroth, Lei Nie, Edvardas Kaminskas, Natasha Kormanik, Kirsten B. Goldberg, Ann T. Farrell, Richard Pazdur
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (22): 6759–6763.
DOI: https://doi.org/10.1158/1078-0432.CCR-16-2870
Published: 14 November 2017
View article
PDF
Journal Articles

FDA Approval: Blinatumomab

Donna Przepiorka, Chia-Wen Ko, Albert Deisseroth, Carolyn L. Yancey, Reyes Candau-Chacon, Haw-Jyh Chiu, Brenda J. Gehrke, Candace Gomez-Broughton, Robert C. Kane, Susan Kirshner, Nitin Mehrotra, Tiffany K. Ricks, Deborah Schmiel, Pengfei Song, Ping Zhao, Qing Zhou, Ann T. Farrell, Richard Pazdur
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (18): 4035–4039.
DOI: https://doi.org/10.1158/1078-0432.CCR-15-0612
Published: 14 September 2015
View article
PDF
Includes: Supplementary data
Journal Articles

FDA Approval: Siltuximab for the Treatment of Patients with Multicentric Castleman Disease

Albert Deisseroth, Chia-Wen Ko, Lei Nie, Jeanne F. Zirkelbach, Liang Zhao, Julie Bullock, Nitin Mehrotra, Pedro Del Valle, Haleh Saber, Christopher Sheth, Brenda Gehrke, Robert Justice, Ann Farrell, Richard Pazdur
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (5): 950–954.
DOI: https://doi.org/10.1158/1078-0432.CCR-14-1678
Published: 01 March 2015
View article
PDF
Journal Articles

U.S. Food and Drug Administration Approval: Carfilzomib for the Treatment of Multiple Myeloma

Thomas M. Herndon, Albert Deisseroth, Edvardas Kaminskas, Robert C. Kane, Kallappa M. Koti, Mark D. Rothmann, Bahru Habtemariam, Julie Bullock, Jeffrey D. Bray, Jessica Hawes, Todd R. Palmby, Josephine Jee, William Adams, Houda Mahayni, Janice Brown, Angelica Dorantes, Rajeshwari Sridhara, Ann T. Farrell, Richard Pazdur
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (17): 4559–4563.
DOI: https://doi.org/10.1158/1078-0432.CCR-13-0755
Published: 02 September 2013
View article
PDF
Journal Articles

U.S. Food and Drug Administration Approval: Ruxolitinib for the Treatment of Patients with Intermediate and High-Risk Myelofibrosis

Albert Deisseroth, Edvardas Kaminskas, Joseph Grillo, Wei Chen, Haleh Saber, Hong L. Lu, Mark D. Rothmann, Satjit Brar, Jian Wang, Christine Garnett, Julie Bullock, Laurie B. Burke, Atiqur Rahman, Rajeshwari Sridhara, Ann Farrell, Richard Pazdur
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (12): 3212–3217.
DOI: https://doi.org/10.1158/1078-0432.CCR-12-0653
Published: 14 June 2012
View article
PDF
Journal Articles

Vector Targeting Makes 5-Fluorouracil Chemotherapy Less Toxic and More Effective in Animal Models of Epithelial Neoplasms

Hakan Akbulut, Yucheng Tang, Jonathan Maynard, Lixin Zhang, Giuseppe Pizzorno, Albert Deisseroth
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (22): 7738–7746.
DOI: https://doi.org/10.1158/1078-0432.CCR-04-0490
Published: 29 November 2004
View article
PDF